Latest Legal News | Orlando Legal Examiner

Bausch & Lomb's Failure to Report

According to a federal warning letter, Bausch & Lomb, the maker of ReNu contact lens solution, failed to report more than 35 foreign cases of fungal eye infection. According to an Associated Press report, “Bausch & Lomb didn’t report the 35 serious injury reports by April 7, as required by law, afte

By The Legal Examiner

/ 7 Nov 2006

Safety of Drug Coated Heart Stents Still Up in the Air

After the third day of Transcather Cardiovascular Therapeutics show, the results are still mixed regarding the safety of drug coated heart stents. The stents, manufactured by Boston Scientific’s Taxus and Johnson & Johnson’s Cypher, many experts agreed, there appears to be a long-term clotting risk

By The Legal Examiner

/ 25 Oct 2006

Bayer's Tardy Report to FDA

Bayer AG has failed to disclose to regulators potentially serious safety concerns about its antibleeding drug Trasylol. The FDA has disclosed that preliminary test results indicate that the drug may cause serious kidney damage, congestive heart failure and strokes and an increased risk of death.

By The Legal Examiner

/ 3 Oct 2006

Two Florida Priests Accused of Pilfering

Two priests stationed at St. Vincent Ferrer Catholic Church in Delray Beach have been accused of absconding with millions in parish funds. The church, located in the Diocese of Palm Beach, lost $8.6 million in funds earmarked for parish operations, a school, and the poor. The two priests, Monsignor

By The Legal Examiner

/ 29 Sep 2006

New Twist in Tobacco Cases

When federal judge Jack Weinstein ruled yesterday that he had found substantial evidence that the so-called light cigarettes were just as dangerous as regular cigarettes and the manufacturers knew it, it opened a potential flood gate of litigants. That’s why Judge Weinstein argued in favor of granti

By The Legal Examiner

/ 26 Sep 2006

Docs Told to Avoid Financial Ties to Drug Research

Physicians’ financial interests should not overtake the needs of a patient when it comes to dealing with drug and medical device manufacturers. This was the obvious conclusion arrived at by a group of bio-ethicists at a conference hosted by Cleveland Clinic and sponsored by the National Institutes o

By The Legal Examiner

/ 21 Sep 2006

Big Tobacco and Big Oil Make Strange Bedfellows

As the 2006 election season heats up, two of the largest industries in the country are pouring millions of dollars into campaigns to keep their corporate profits rolling. A recent San Francisco Chronicle article on big tobacco, the author states that oil and tobacco are pouring huge sums of money in

By The Legal Examiner

/ 20 Sep 2006

Boston Scientific Confirms Increased Risk Linked to its Stent

A leading stent manufacturer has admitted that there is an increased clot risk for those with Boston Scientific’s cardiac stent. It is the first acknowledgment by a stent maker of an increased risk of the dangerous side effect of stents, which are small wire-mesh tubes used to keep previously clogge

By The Legal Examiner

/ 7 Sep 2006

Bausch & Lomb Infections Lead to Corneal Transplants

About 1/3 of those who’ve experienced eye infections as a result of the use of Bausch & Lomb’s ReNu eye contact solution are schedule to undergo corneal transplants. These new findings will be published in the Journal of the American Medical Association at the end of this month.

By The Legal Examiner

/ 23 Aug 2006

Big Tobacco Better Exhale

A US District Judge ruled yesterday that big tobacco companies conspired for years to hide the deadly effects of cigarette smoke from the public. This isn’t suprising to most of us who’ve followed these battles. However, it will most likely lead to a groundswell of lawsuits against big tobacco. For

By The Legal Examiner

/ 22 Aug 2006

Glaxo Smith Kline Adds Warning to Drug

According to a published report in the Wall St. Journal, Glaxo Smith Kline became the latest drug manufacturer to add a warning label to its ADHD drug, Dexedrine. The new warning label will include a warning about cardiac risks and psychiatric side effects. The new warning was posted on the FDA webs

By The Legal Examiner

/ 22 Aug 2006

Big Defeat for Merck, Maker of Vioxx

A New Orleans jury returned a $50,000,000 award to a 62 year old plaintiff who had taken Vioxx for 31 months. Mr. Barnett had suffered a heart attack four years earlier and stopped taking the drug shortly before Vioxx was pulled from the market. The jury found that Merck failed to adequately warn do

By The Legal Examiner

/ 17 Aug 2006